Mechanisms regulating skeletal muscle growth and atrophy - PubMed (original) (raw)
Review
. 2013 Sep;280(17):4294-314.
doi: 10.1111/febs.12253. Epub 2013 Apr 17.
Affiliations
- PMID: 23517348
- DOI: 10.1111/febs.12253
Free article
Review
Mechanisms regulating skeletal muscle growth and atrophy
Stefano Schiaffino et al. FEBS J. 2013 Sep.
Free article
Abstract
Skeletal muscle mass increases during postnatal development through a process of hypertrophy, i.e. enlargement of individual muscle fibers, and a similar process may be induced in adult skeletal muscle in response to contractile activity, such as strength exercise, and specific hormones, such as androgens and β-adrenergic agonists. Muscle hypertrophy occurs when the overall rates of protein synthesis exceed the rates of protein degradation. Two major signaling pathways control protein synthesis, the IGF1-Akt-mTOR pathway, acting as a positive regulator, and the myostatin-Smad2/3 pathway, acting as a negative regulator, and additional pathways have recently been identified. Proliferation and fusion of satellite cells, leading to an increase in the number of myonuclei, may also contribute to muscle growth during early but not late stages of postnatal development and in some forms of muscle hypertrophy in the adult. Muscle atrophy occurs when protein degradation rates exceed protein synthesis, and may be induced in adult skeletal muscle in a variety of conditions, including starvation, denervation, cancer cachexia, heart failure and aging. Two major protein degradation pathways, the proteasomal and the autophagic-lysosomal pathways, are activated during muscle atrophy and variably contribute to the loss of muscle mass. These pathways involve a variety of atrophy-related genes or atrogenes, which are controlled by specific transcription factors, such as FoxO3, which is negatively regulated by Akt, and NF-κB, which is activated by inflammatory cytokines.
Keywords: FoxO; IGF1; mTOR; muscle atrophy; muscle hypertrophy; myostatin; protein degradation; protein synthesis; satellite cells.
© 2013 The Authors Journal compilation © 2013 FEBS.
Similar articles
- Role of satellite cells in muscle growth and maintenance of muscle mass.
Pallafacchina G, Blaauw B, Schiaffino S. Pallafacchina G, et al. Nutr Metab Cardiovasc Dis. 2013 Dec;23 Suppl 1:S12-8. doi: 10.1016/j.numecd.2012.02.002. Epub 2012 May 22. Nutr Metab Cardiovasc Dis. 2013. PMID: 22621743 Review. - Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. Bodine SC, et al. Nat Cell Biol. 2001 Nov;3(11):1014-9. doi: 10.1038/ncb1101-1014. Nat Cell Biol. 2001. PMID: 11715023 - Myoblast models of skeletal muscle hypertrophy and atrophy.
Sharples AP, Stewart CE. Sharples AP, et al. Curr Opin Clin Nutr Metab Care. 2011 May;14(3):230-6. doi: 10.1097/MCO.0b013e3283457ade. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21460719 Review. - The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
Lan XQ, Deng CJ, Wang QQ, Zhao LM, Jiao BW, Xiang Y. Lan XQ, et al. Gen Comp Endocrinol. 2024 Jul 1;353:114513. doi: 10.1016/j.ygcen.2024.114513. Epub 2024 Apr 10. Gen Comp Endocrinol. 2024. PMID: 38604437 Review. - Prolonged absence of myostatin reduces sarcopenia.
Siriett V, Platt L, Salerno MS, Ling N, Kambadur R, Sharma M. Siriett V, et al. J Cell Physiol. 2006 Dec;209(3):866-73. doi: 10.1002/jcp.20778. J Cell Physiol. 2006. PMID: 16972257
Cited by
- Therapeutic potential of omaveloxolone in counteracting muscle atrophy post-denervation: a multi-omics approach.
Wang S, Yang X, Liu K, Xiong D, Yalikun A, Hamiti Y, Yusufu A. Wang S, et al. J Transl Med. 2024 Nov 2;22(1):991. doi: 10.1186/s12967-024-05810-7. J Transl Med. 2024. PMID: 39487481 Free PMC article. - The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis.
Russo C, Surdo S, Valle MS, Malaguarnera L. Russo C, et al. Int J Mol Sci. 2024 Oct 21;25(20):11310. doi: 10.3390/ijms252011310. Int J Mol Sci. 2024. PMID: 39457092 Free PMC article. Review. - The Effects of Heat Therapy During Immobilization and Rehabilitation on Muscle Atrophy and Strength Loss at Return to Sports in Healthy Humans.
Labidi M, Alhammoud M, Mtibaa K, Ihsan M, Deldicque L, Nasir N, Papakostas E, Olory B, Cruz F, Farooq M, Sanchez AMJ, d'Hooghe P, Tourny C, Racinais S. Labidi M, et al. Orthop J Sports Med. 2024 Oct 21;12(10):23259671241281727. doi: 10.1177/23259671241281727. eCollection 2024 Oct. Orthop J Sports Med. 2024. PMID: 39444938 Free PMC article. - Phase angle variability on bleeding risks in hemodialysis patients.
Ohta M, Kan T, Yoshida Y, Sato H, Hoshino T, Sato T, Hoshino Y. Ohta M, et al. Clin Exp Nephrol. 2024 Oct 15. doi: 10.1007/s10157-024-02577-5. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 39406994 - Sorafenib induces cachexia by impeding transcriptional signaling of the SET1/MLL complex on muscle-specific genes.
Khan B, Lanzuolo C, Rosti V, Santarelli P, Pich A, Kraft T, Amrute-Nayak M, Nayak A. Khan B, et al. iScience. 2024 Sep 10;27(10):110913. doi: 10.1016/j.isci.2024.110913. eCollection 2024 Oct 18. iScience. 2024. PMID: 39386761 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous